Abstract
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) have evolved as sensitive tools for anatomic and metabolic evaluation of breast cancer. In vivo MRS studies have documented the presence of choline containing compounds (tCho) as a reliable biochemical marker of malignancy and also useful for monitoring the tumor response to therapy. Recent studies on the absolute quantification of tCho are expected to provide cut-off values for discrimination of various breast pathologies. Addition of MRS investigation was also reported to increase the specificity of MRI. Further, ex vivo and in vitro MRS studies of intact tissues and tissue extracts provided several metabolites that were not be detected in vivo and provided insight into underlying biochemistry of the disease processes. In this review, we present briefly the role of various 1H MRS methods used in breast cancer research and their potential in relation to diagnosis, monitoring of therapeutic response and metabolism.
Similar content being viewed by others
References
Baek HM, Chen JH, Yu HJ et al (2008) Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging 27:1114–1121 doi:10.1002/jmri.21309
Baik HM, Su MY, Yu H et al (2006) Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. Magn Reson Mater Phy 19:96–104 doi:10.1007/s10334-006-0032-4
Bartella L, Morris EA, Dershaw DD et al (2006) Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 239:686–692 doi:10.1148/radiol.2393051046
Bartella L, Thakur SB, Morris EA et al (2007) Enhancing non-mass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology 245:80–87 doi:10.1148/radiol.2451061639
Bathen TF, Jensen LR, Sitter B et al (2007) MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 104:181–189 doi:10.1007/s10549-006-9400-z
Beckonert O, Monnerjahn J, Bonk U et al (2003) Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed 16:1–11 doi:10.1002/nbm.797
Bolan PJ, Meisamy S, Baker EH et al (2003) In-vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134–1143 doi:10.1002/mrm.10654
Bolan PJ, Henry PG, Baker EH et al (2004) Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med 52:1239–1245 doi:10.1002/mrm.20277
Bolan PJ, Snyder CJ, DelaBarre LJ et al (2006) Preliminary experience with breast 1H MRS at 7 Tesla. Proc Int Soc Magn Reson Med 14:580
Cecil KM, Schnall MD, Siegelman ES et al (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45–54 doi:10.1023/A:1017911211090
Cheng LL, Chang IW, Smith BL et al (1998) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 135:194–202 doi:10.1006/jmre.1998.1578
Danishad KA, Seenu V, Jagannathan NR (2007) 2D MRSI in locally advanced breast cancer: Assessment of tumor response in patients undergoing neo-adjuvant chemotherapy. Proc Int Soc Mag Reson Med 15:557
Do R, Moy L, Salibi N et al (2006) Can MRS improve our ability to distinguish between benign and malignant lesions? Proc Int Soc Magn Reson Med 14:2876
Gary MT, Cheung HS, Pang L et al (2003) Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR 181:1267–1273
Gary MT, David KY, Ann DK et al (2007) In-vivo magnetic resonance spectroscopy of breast cancer lesions: an update. Breast Cancer Res Treat 104:249–255 doi:10.1007/s10549-006-9412-8
Glunde K, Jie C, Bhujwalla ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64:4270–4276 doi:10.1158/0008-5472.CAN-03-3829
Greenlee RT, Hill-Harmon MB, Murray T et al (2001) Cancer statistics. CA Cancer J Clin 51:5–36
Gribbestad IS, Petersen SB, Fjosne HE et al (1994) 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 7:181–194 doi:10.1002/nbm.1940070405
Jagannathan NR, Singh M, Govindaraju V et al (1998) Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water–fat ratio in patients receiving chemotherapy. NMR Biomed 11:414–422. doi:10.1002/(SICI)1099-1492(199812)11:8<414::AID-NBM537>3.0.CO;2-W
Jagannathan NR, Kumar M, Raghunathan P et al (1999) Assessment of the therapeutic response of human breast carcinoma using in vivo volume localized proton magnetic resonance spectroscopy. Curr Sci 76:777–782
Jagannathan NR, Kumar M, Seenu V et al (2001) Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016–1022 doi:10.1054/bjoc.2000.1711
Katz-Brull R, Lavin PT, Lenkinski RE (2002a) Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 94:1197–1203
Katz-Brull R, Seger D, Rivenson-Segal D et al (2002b) Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline–ether–phospholipid synthesis. Cancer Res 62:1966–1970
Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy and transfer to clinical practice. Radiology 244:356–378 doi:10.1148/radiol.2442051620
Kumar M, Seenu V, Julka PK et al (2005) Proton MR spectroscopy of human breast cancer. In: Jagannathan NR (ed) Recent advances in MR imaging and spectroscopy. Jaypee, New Delhi, pp 312–344
Kumar M, Jagannathan NR, Seenu V et al (2006) Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in-vivo proton MR spectroscopy study. J Magn Reson Imaging 24:325–332 doi:10.1002/jmri.20646
Kvistad KA, Bakken IJ, Gribbestad IS et al (1999) Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn Reson Imaging 10:159–164 doi:10.1002/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0
Mackinnon WB, Barry PA, Malycha PL et al (1997) Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex-vivo with proton MR spectroscopy. Radiology 204:661–666
Meisamy S, Bolan PJ, Baker EH et al (2004) Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in-vivo 1H MR spectroscopy—a pilot study at 4 T. Radiology 233:424–431 doi:10.1148/radiol.2332031285
Meisamy S, Bolan PJ, Baker EH et al (2005) Adding in-vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 236:465–475 doi:10.1148/radiol.2362040836
Mescher M, Tannus A, Johnson MO’N et al (1996) Solvent suppression using selective echo dephasing. J Magn Reson 123:226–229 doi:10.1006/jmra.1996.0242
Mountford CE, Somorjai RL, Malycha P et al (2001) Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 88:1234–1240 doi:10.1046/j.0007-1323.2001.01864.x
Roebuck JR, Cecil KM, Schnall MD et al (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269–275
Sardanelli F, Fausto A, Podo F (2008) MR spectroscopy of the breast. Radiol Med (Torino) 113:56–64 doi:10.1007/s11547-008-0228-y
Seenu V, Pavan Kumar MN et al (2005) Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer. Magn Reson Imaging 23:1005–1010 doi:10.1016/j.mri.2005.10.004
Sharma U, Mehta A, Seenu V et al (2004) Biochemical characterization of metastatic lymph nodes of breast cancer patients by in vitro 1H magnetic resonance spectroscopy: a pilot study. Magn Reson Imaging 22:697–706 doi:10.1016/j.mri.2004.01.037
Sharma U, Jagannathan NR (2006a) In-vivo magnetic resonance (MR) spectroscopy in breast cancer. In: Webb GA (ed) Modern magnetic resonance. Springer, Netherlands, pp 1063–1072
Sharma U, Sharma R, Jagannathan NR (2006b) Characterization of breast lesions by magnetic resonance imaging (MRI) and spectroscopy (MRS). Curr Med Imaging Rev 2:329–340 doi:10.2174/157340506777934525
Sijens PE, Wijrdeman HK, Moerland MA et al (1988) Human breast cancer in vivo: 1H and 31P MR spectroscopy at 1.5 T. Radiology 169:615–620
Sitter B, Sonnewald U, Spraul M et al (2002) High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15:327–337 doi:10.1002/nbm.775
Sitter B, Lundgren S, Bathen TF et al (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19:30–40 doi:10.1002/nbm.992
Stanwell P, Gluch L, Clark D et al (2005) Specificity of choline metabolites for in-vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol 15:1037–1043 doi:10.1007/s00330-004-2475-1
Thomas MA, Wyckoff N, Yue K et al (2005) Two-dimensional MR spectroscopic characterization of breast cancer in-vivo. Technol Cancer Res Treat 4:99–106
Whitehead TL, Kieber-Emmons T (2005) Applying in-vitro NMR spectroscopy and 1H NMR metabonomics to breast cancer characterization and detection. Prog Nucl Magn Reson Spectrosc 47:165–174 doi:10.1016/j.pnmrs.2005.09.001
Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in-vivo proton MR spectroscopy-initial results. Radiology 220:40–46
Acknowledgments
The authors thank Profs. G.K. Rath, P.K. Julka, A. Srivastava, S. D. Gupta, R. Parshad, V. Seenu, S. N. Dwivedi, R. Sharma, Dr. M. Kumar, Mr. K. A. Danishad and Ms. R. G. Sah for their help, support and for many fruitful discussions. The Department of Science and Technology, Government of India is acknowledged for financial support (SP/S0/B27/95, SP/S0/B21/2001and SP/S0/HS-80/2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, U., Jagannathan, N.R. Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS). Biophys Rev 1, 21–26 (2009). https://doi.org/10.1007/s12551-008-0004-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12551-008-0004-1